Page last updated: 2024-10-31

naratriptan and Meningitis, Pneumococcal

naratriptan has been researched along with Meningitis, Pneumococcal in 1 studies

naratriptan: structure given in first source

Meningitis, Pneumococcal: An acute purulent infection of the meninges and subarachnoid space caused by Streptococcus pneumoniae, most prevalent in children and adults over the age of 60. This illness may be associated with OTITIS MEDIA; MASTOIDITIS; SINUSITIS; RESPIRATORY TRACT INFECTIONS; sickle cell disease (ANEMIA, SICKLE CELL); skull fractures; and other disorders. Clinical manifestations include FEVER; HEADACHE; neck stiffness; and somnolence followed by SEIZURES; focal neurologic deficits (notably DEAFNESS); and COMA. (From Miller et al., Merritt's Textbook of Neurology, 9th ed, p111)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hoffmann, O1
Keilwerth, N1
Bille, MB1
Reuter, U1
Angstwurm, K1
Schumann, RR1
Dirnagl, U1
Weber, JR1

Other Studies

1 other study available for naratriptan and Meningitis, Pneumococcal

ArticleYear
Triptans reduce the inflammatory response in bacterial meningitis.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2002, Volume: 22, Issue:8

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzamides; Calcitonin Gene-Related Peptide; Cereb

2002